Bristol-Myers Squibb, XILDHIBAAN-76K, FDA, melanoma, Cajiib
Nivolumab waxa u ansixisay FDA daawaynta adjuvant ee Marxaladda IIB/C melanoma
Noofambar 2023: Nivolumab (Opdivo, Bristol-Myers Squibb Company) waxa oggolaaday Maamulka Cuntada iyo Dawooyinka sida daawayn kaabayaal ah oo loogu talagalay Marxaladda IIB/C melanoma ee bukaannada 12 sano jir iyo ka weyn oo si dhammaystiran loo maray.
BMS, Bristol Myers Squibb, immunotherapy, melanoma metastatic, nivolumab iyo relatlimab, nivolumab iyo relatlimab-rmbw, Opdualag, USFDA
Marka hore LAG-3-Blocking antibody isku darka, Opdualag™ (nivolumab iyo relatlimab-rmbw), waxa u ansixisay FDA bukaanada qaba melanoma aan la dabooli karin ama metastatic
Abriil 2022: Maamulka Cunnada iyo Dawooyinka ee Mareykanka (FDA) ayaa ansixiyay Opdualag (nivolumab iyo relatlimab-rmbw), cusub, fasalka koowaad-ku-jira qiyaas go'an oo isku darka nivolumab iyo relatlimab oo loo maamulo faleebo hal xidid xididka ah, f..
Shirkadda Immunocore Limited waxay ku saleysantahay Maraykanka, Kimmtrak, melanoma metastatic uveal, tebentafusp-tebn, melanoma uveal
Tebentafusp-tebn waxaa loo oggolaaday melanoma aan la soo saari karin ama metastatic uveal melanoma
Maarso 2022: Tebentafusp-tebn (Kimmtrak, Immunocore Limited), gp100 peptide-HLA-ku hagayo CD3 T unug, waxa shati ka siisay Maamulka Cuntada iyo Dawooyinka ee HLA-A*02:01- bukaanada qaangaarka ah ee togan ee qaba unrectab. .
CD-38, FDA, Horizon, wakiilka immunomodulatory, milphalan flufenamide, Meelo badan, NCT02963493, Oncopeptides AB, Pepaxto
Melphalan flufenamide waxay oggolaansho ka heshaa FDA dib -u -noqoshada ama diidmada badan ee myeloma
Ogosto 2021: Melphalan flufenamide (Pepaxto, Oncopeptides AB) oo ay weheliso dexamethasone ayaa Maamulka Cuntada iyo Dawooyinka siisay oggolaansho degdeg ah bukaannada qaangaarka ah ee soo noqnoqday ama diidaya malax badan.
KEYTRUDA, Merck, NCT02362594, Pembrolizumab, DIIWAAN, USFDA
Pembrolizumab waxaa ansixiyay FDA si loogu daaweeyo daawada 'melanoma'
Febraayo 15, 2019, pembrolizumab (KEYTRUDA, Merck) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee daawaynta adjuvant ee bukaannada qaba melanoma oo ay ku lug leeyihiin qanjidhada qanjidhada (s) ka dib dib-u-soo-celin buuxda. Oggolaanshaha
Qalliinka Bariatric, Delhi, Hindiya, USA
Qalliinka Bariatric wuxuu yarayn karaa halista melanoma
Marka lagu daro miisaan lumis deg deg ah oo waara iyo faa iidooyin kale oo caafimaad, qalliinka bariatric waxaa hadda lala xiriirinayaa halista 61% ee halista melanoma malignant, taas oo ah kansarka maqaarka ugu dilaaga ah ee aadka ugu dhow dhow s.